Literature DB >> 16521221

Expression, purification and characterization of enterovirus-71 virus-like particles.

Yao-Chi Chung1, Jen-Huang Huang, Chia-Wei Lai, Heng-Chun Sheng, Shin-Ru Shih, Mei-Shang Ho, Yu-Chen Hu.   

Abstract

AIM: Enterovirus 71 (EV71) has been implicated as the etiological agent responsible for the recent outbreaks of hand, foot and mouth disease associated with severe neurological diseases in the Asia-Pacific region.
METHODS: The assembly process was hypothesized to occur via an orchestrated proteolytic processing of the P1 precursor by the viral protease 3CD. To test this hypothesis, we constructed 3 recombinant baculoviruses: Bac-P1 expressing P1; Bac-3CD expressing 3CD; and Bac-P1-3CD co-expressing P1 and 3CD.
RESULTS: Both single infection by Bac-P1-3CD and co-infection by Bac-P1 and Bac-3CD resulted in correct cleavage of P1 to yield individual proteins VP0, VP1 and VP3, while the former approach yielded higher VLP production. In the cells, the structural proteins self-assembled into clusters of virus-like particles (VLP) resembling the authentic EV71 particle aggregates. After ultracentrifugation purification, the dispersed VLPs were indistinguishable from the authentic virus in size, appearance, composition and surface epitopes, as determined by SDS-PAGE, Western blot, transmission electron microscopy and immunogold labeling.
CONCLUSION: Our data, for the first time, suggest that in insect cells EV71 structural proteins adopt a processing and assembly pathway similar to poliovirus assembly. The preservation of particle morphology and composition suggest that the VLP may be a valuable vaccine candidate to prevent EV71 epidemics.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16521221      PMCID: PMC4066158          DOI: 10.3748/wjg.v12.i6.921

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  43 in total

1.  A comparison of WIN 51711 and R 78206 as stabilizers of poliovirus virions and procapsids.

Authors:  B Rombaut; K Andries; A Boeyé
Journal:  J Gen Virol       Date:  1991-09       Impact factor: 3.891

2.  In vitro assembly of poliovirus 14 S subunits: identification of the assembly promoting activity of infected cell extracts.

Authors:  B Rombaut; A Foriers; A Boeyé
Journal:  Virology       Date:  1991-02       Impact factor: 3.616

3.  Antigenic structure of polioviruses of serotypes 1, 2 and 3.

Authors:  P D Minor; M Ferguson; D M Evans; J W Almond; J P Icenogle
Journal:  J Gen Virol       Date:  1986-07       Impact factor: 3.891

4.  New evidence for the precursor role of 14 S subunits in poliovirus morphogenesis.

Authors:  B Rombaut; R Vrijsen; A Boeyé
Journal:  Virology       Date:  1990-07       Impact factor: 3.616

5.  Protein 3CD is the major poliovirus proteinase responsible for cleavage of the P1 capsid precursor.

Authors:  M F Ypma-Wong; P G Dewalt; V H Johnson; J G Lamb; B L Semler
Journal:  Virology       Date:  1988-09       Impact factor: 3.616

6.  Monoplegia caused by Enterovirus 71: an outbreak in Hong Kong.

Authors:  G M Samuda; W K Chang; C Y Yeung; P S Tang
Journal:  Pediatr Infect Dis J       Date:  1987-02       Impact factor: 2.129

7.  A second virus-encoded proteinase involved in proteolytic processing of poliovirus polyprotein.

Authors:  H Toyoda; M J Nicklin; M G Murray; C W Anderson; J J Dunn; F W Studier; E Wimmer
Journal:  Cell       Date:  1986-06-06       Impact factor: 41.582

8.  Outbreak of enterovirus 71 infection in Victoria, Australia, with a high incidence of neurologic involvement.

Authors:  G L Gilbert; K E Dickson; M J Waters; M L Kennett; S A Land; M Sneddon
Journal:  Pediatr Infect Dis J       Date:  1988-07       Impact factor: 2.129

9.  Synthesis of immunogenic, but non-infectious, poliovirus particles in insect cells by a baculovirus expression vector.

Authors:  T Urakawa; M Ferguson; P D Minor; J Cooper; M Sullivan; J W Almond; D H Bishop
Journal:  J Gen Virol       Date:  1989-06       Impact factor: 3.891

10.  Coinfection with recombinant vaccinia viruses expressing poliovirus P1 and P3 proteins results in polyprotein processing and formation of empty capsid structures.

Authors:  D C Ansardi; D C Porter; C D Morrow
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

View more
  32 in total

1.  Use of a baculovirus-expressed structural protein for the detection of antibodies to foot-and-mouth disease virus type A by a blocking enzyme-linked immunosorbent assay.

Authors:  Young-Joon Ko; Hyang-Sim Lee; Hye-Young Jeoung; Eun-Jeong Heo; Hyo-Rim Ko; Byung-Sik Chang; Hoo-Don Joo; U Gerelmaa; B Dashzeveg; S Tserendorj; R Sodnomdarjaa; Jong-Hyeon Park; Chang-Hee Kweon; In-Soo Cho; Sang-Gi Paik
Journal:  Clin Vaccine Immunol       Date:  2009-11-04

2.  Structure, Immunogenicity, and Protective Mechanism of an Engineered Enterovirus 71-Like Particle Vaccine Mimicking 80S Empty Capsid.

Authors:  Xiaoli Wang; Zhiqiang Ku; Xiang Zhang; Xiaohua Ye; Jinhuan Chen; Qingwei Liu; Wei Zhang; Chao Zhang; Zhenglin Fu; Xia Jin; Yao Cong; Zhong Huang
Journal:  J Virol       Date:  2017-12-14       Impact factor: 5.103

3.  Cryo-electron microscopy study of insect cell-expressed enterovirus 71 and coxsackievirus a16 virus-like particles provides a structural basis for vaccine development.

Authors:  Minqing Gong; Hongtao Zhu; Jun Zhou; Chunting Yang; Jing Feng; Xiaojun Huang; Gang Ji; Honglin Xu; Ping Zhu
Journal:  J Virol       Date:  2014-03-26       Impact factor: 5.103

4.  Development and characterization of an enterovirus 71 (EV71) virus-like particles (VLPs) vaccine produced in Pichia pastoris.

Authors:  Zhijian Yang; Fan Gao; Xiaoliang Wang; Likang Shi; Zheng Zhou; Yuanxiang Jiang; Xinxing Ma; Chao Zhang; Chenliang Zhou; Xianfang Zeng; Ge Liu; Jiang Fan; Qunying Mao; Li Shi
Journal:  Hum Vaccin Immunother       Date:  2019-08-15       Impact factor: 3.452

5.  In vitro assembly of an empty picornavirus capsid follows a dodecahedral path.

Authors:  Chenglei Li; Joseph Che-Yen Wang; Milton W Taylor; Adam Zlotnick
Journal:  J Virol       Date:  2012-09-26       Impact factor: 5.103

6.  Evaluation of monovalent and bivalent vaccines against lethal Enterovirus 71 and Coxsackievirus A16 infection in newborn mice.

Authors:  Shiyang Sun; Liping Jiang; Zhenglun Liang; Qunying Mao; Weiheng Su; Huafei Zhang; Xiaojun Li; Jun Jin; Lin Xu; Dandan Zhao; Peihu Fan; Dong An; Ping Yang; Jingcai Lu; Xiuping Lv; Bo Sun; Fei Xu; Wei Kong; Chunlai Jiang
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

7.  Characterization of Coxsackievirus B4 virus-like particles VLP produced by the recombinant baculovirus-insect cell system expressing the major capsid protein.

Authors:  Ikbel Hadj Hassine; Jawhar Gharbi; Bechr Hamrita; Mohammed A Almalki; José Francisco Rodríguez; Manel Ben M'hadheb
Journal:  Mol Biol Rep       Date:  2020-04-02       Impact factor: 2.316

Review 8.  Progress on the research and development of human enterovirus 71 (EV71) vaccines.

Authors:  Zhenglun Liang; Qunying Mao; Fan Gao; Junzhi Wang
Journal:  Front Med       Date:  2012-12-17       Impact factor: 4.592

9.  Foot-and-mouth disease virus assembly: processing of recombinant capsid precursor by exogenous protease induces self-assembly of pentamers in vitro in a myristoylation-dependent manner.

Authors:  Stewart Goodwin; Tobias J Tuthill; Armando Arias; Richard A Killington; David J Rowlands
Journal:  J Virol       Date:  2009-08-26       Impact factor: 5.103

10.  Human IgG subclasses against enterovirus Type 71: neutralization versus antibody dependent enhancement of infection.

Authors:  Rui-Yuan Cao; Da-Yong Dong; Rui-Ju Liu; Jian-Feng Han; Guang-Chuan Wang; Hui Zhao; Xiao-Feng Li; Yong-Qiang Deng; Shun-Ya Zhu; Xiao-Yu Wang; Fang Lin; Fu-Jun Zhang; Wei Chen; E-De Qin; Cheng-Feng Qin
Journal:  PLoS One       Date:  2013-05-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.